Pepto-Bismol

Product NDC: 52904-903
Requested package NDC: 52904-903-04
11-digit product format: 529040903
Labeler code: 52904
Product ID: 52904-903_25d8dc24-31e7-48f3-97c5-31cc02bdd787
Type: HUMAN OTC DRUG
Nonproprietary name: bismuth subsalicylate
Dosage form: TABLET
Route: ORAL
Labeler: Select Corporation
Application: part335
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2004-06-30
Marketing end: 0000-00-00
Substance: BISMUTH SUBSALICYLATE
Active strength: 262 mg/1
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	52904-903	52904-903-04	I	Inactivated by FDA		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 15 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	`1332a3947898…`	`d4bfe170f9cd…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
a62a50ac-1535-4461-9768-8ae703e2e9fb	Product name	1	20210525
dea2eded-d1e7-46bb-9a3d-f8dc20de6277	Product name	1	20190408
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
bc07ef78-e82d-0c19-31f4-31f263780582	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
52904-903-04	2024-01-30	C162847	48780-1	1030e365-0816-111a-e063-dadaa90a10e2	Pepto-Bismol ™ Chewable Tablets
52904-903-05	2024-01-30	C162847	48780-1	1030e365-0816-111a-e063-dadaa90a10e2	Pepto-Bismol ™ Chewable Tablets

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
52904-903-04	Pepto-Bismol	2 in 1 POUCH	TABLET	2	1
52904-903-04	Pepto-Bismol	1 in 1 BLISTER PACK	TABLET	1	1
52904-903-05	Pepto-Bismol	2 in 1 POUCH	TABLET	2	1
52904-903-05	Pepto-Bismol	2 in 1 BLISTER PACK	TABLET	2	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
52904-903	PEPTO-BISMOL (BISMUTH SUBSALICYLATE) TABLET [SELECT CORPORATION]	1	Legacy NDC, 4 package rows	20220416_0b3a5a1a-2c1b-48ce-a3fe-bbcda23631f3.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
62TEY51RR1	BISMUTH SUBSALICYLATE	14882-18-9	BISMUTH SUBSALICYLATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
308761	bismuth subsalicylate 262 MG Chewable Tablet	PSN	0b3a5a1a-2c1b-48ce-a3fe-bbcda23631f3	1
211151	Pepto-Bismol 262 MG Chewable Tablet	PSN	0b3a5a1a-2c1b-48ce-a3fe-bbcda23631f3	1
211151	bismuth subsalicylate 262 MG Chewable Tablet [Pepto-bismol]	SBD	0b3a5a1a-2c1b-48ce-a3fe-bbcda23631f3	1
308761	bismuth subsalicylate 262 MG Chewable Tablet	SCD	0b3a5a1a-2c1b-48ce-a3fe-bbcda23631f3	1
211151	Pepto-bismol 262 MG Chewable Tablet	SY	0b3a5a1a-2c1b-48ce-a3fe-bbcda23631f3	1
211151	Pepto-Bismol InstaCool 262 MG Chewable Tablet	SY	0b3a5a1a-2c1b-48ce-a3fe-bbcda23631f3	1
211151	Pepto-Bismol To-Go 262 MG Chewable Tablet	SY	0b3a5a1a-2c1b-48ce-a3fe-bbcda23631f3	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
52904-903-04	52904090304	1 POUCH in 1 BLISTER PACK (52904-903-04) > 2 TABLET in 1 POUCH	1 pouch	2004-06-30	0000-00-00	No	No	Current